In vitro and in silico study to evaluate the effectiveness of quercitrin as antiviral drug to dengue virus
Open Access
- 10 December 2019
- conference paper
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2193 (1) , 030004
Abstract
Dengue Fever (DF) in Indonesia has been a major health problem for the last 47 years, which keeps on rising until today. Quercitrin as one of the natural compounds, flavonol group and has been used in several types of research for their properties of anti-inflammation, anti-bacterial, anti-viral, and anti-fungi. The aim of this study was to explore the potency of quercitrin as an antiviral drug to dengue virus (DENV) in vitro and in silico. We used Focus assay, MTT assay, and docking analysis to determine IC50, CC50 and binding energy, respectively. The IC50, CC50 and Selectivity Index (SI) of quercitrin was 1.1 µg/ml, 38.8 µg/ml and 38 respectively. In silico study showed the binding energy between quercitrin and NS5 protein was −7,54 kkal/mol. The results obtained that Quercutrin as a good candidate for an antiviral drug to DENV in the future.Keywords
This publication has 12 references indexed in Scilit:
- Antioxidant Activity of Quercetin and Its Glucosides from Propolis: A Theoretical StudyScientific Reports, 2017
- In vitro study of eight Indonesian plants extracts as anti Dengue virusHealth Science Journal of Indonesia, 2017
- Dengue Fever: Causes, Complications, and Vaccine StrategiesJournal of Immunology Research, 2016
- Novel antiviral activity of bromocriptine against dengue virus replicationAntiviral Research, 2016
- Quercetin, Inflammation and ImmunityNutrients, 2016
- Overviews of biological importance of quercetin: A bioactive flavonoidPharmacognosy Reviews, 2016
- Dengue viruses – an overviewInfection Ecology & Epidemiology, 2013
- Antiviral activity of four types of bioflavonoid against dengue virus type-2Virology Journal, 2011
- Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin‐induced diabetic tissues by altering glycolytic and gluconeogenic enzymesFundamental & Clinical Pharmacology, 2010
- In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐κB pathwayEuropean Journal of Immunology, 2005